Literature DB >> 19380721

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.

Matthew R Lincoln1, Sreeram V Ramagopalan, Michael J Chao, Blanca M Herrera, Gabriele C Deluca, Sarah-Michelle Orton, David A Dyment, A Dessa Sadovnick, George C Ebers.   

Abstract

Multiple sclerosis (MS), a common central nervous system inflammatory disease, has a major heritable component. Susceptibility is associated with the MHC class II region, especially HLA-DRB5*0101-HLA-DRB1*1501-HLA-DQA1*0102-HLA-DQB1*0602 haplotypes(hereafter DR2), which dominate genetic contribution to MS risk. Marked linkage disequilibrium (LD) among these loci makes identification of a specific locus difficult. The once-leading candidate, HLA-DRB1*15, localizes to risk, neutral, and protective haplotypes. HLA-DRB1*15 and HLA-DQB1*0602, nearly always located together on a small ancestral chromosome segment, are strongly MS-associated. One intervening allele on this haplotype, viz. HLA-DQA1*0102, shows no primary MS association. Two Canadian cohorts (n = 830 and n = 438 trios) genotyped for HLA-DRB1, HLA-DQA1 and HLA-DQB1 alleles were tested for association using TDT. To evaluate epistasis involving HLA-DRB1*15, transmissions from HLA-DRB1*15-negative parents were stratified by the presence/absence of HLA-DRB1*15 in affected offspring. All 3 alleles contribute to MS susceptibility through novel epistatic interactions. HLA-DQA1*0102 increased disease risk when combined with HLA-DRB1*1501 in trans, thereby unambiguously implicating HLA-DQ in MS susceptibility. Three-locus haplotypes demonstrated that HLA-DRB1*1501 and HLA-DQB1*0602 each influence risk. Transmissions of rare morcellated DR2 haplotypes showed no interaction with HLA-DQA1*0102. Incomplete haplotypes bearing only HLA-DRB1*1501 or HLA-DQB1*0602 did not predispose to MS. Balanced reciprocal transmission distortion can mask epistatic allelic association. These findings implicate epistasis among HLA class II alleles in human immune responses generally, provide partial explanation for intense linkage disequilibrium in the MHC, have relevance to animal models, and demonstrate key roles for DR2-specific interactions in MS susceptibility. MHC disease associations may be more generally haplotypic or diplotypic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380721      PMCID: PMC2678609          DOI: 10.1073/pnas.0812664106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.

Authors:  David A Dyment; Blanca M Herrera; M Zameel Cader; Cristen J Willer; Matthew R Lincoln; A Dessa Sadovnick; Neil Risch; George C Ebers
Journal:  Hum Mol Genet       Date:  2005-06-01       Impact factor: 6.150

2.  A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group.

Authors:  G C Ebers; A D Sadovnick; N J Risch
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

Review 3.  The T lymphocyte in experimental allergic encephalomyelitis.

Authors:  S S Zamvil; L Steinman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis.

Authors:  Matthew R Lincoln; Alexandre Montpetit; M Zameel Cader; Janna Saarela; David A Dyment; Milvi Tiislar; Vincent Ferretti; Pentti J Tienari; A Dessa Sadovnick; Leena Peltonen; George C Ebers; Thomas J Hudson
Journal:  Nat Genet       Date:  2005-09-25       Impact factor: 38.330

5.  A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.

Authors:  L S Madsen; E C Andersson; L Jansson; M krogsgaard; C B Andersen; J Engberg; J L Strominger; A Svejgaard; J P Hjorth; R Holmdahl; K W Wucherpfennig; L Fugger
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

6.  HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.

Authors:  Meenakshi Khare; Ashutosh Mangalam; Moses Rodriguez; Chella S David
Journal:  J Neuroimmunol       Date:  2005-09-27       Impact factor: 3.478

7.  Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Helmut Butzkueven; Ingrid A F van Der Mei; Michèle M Sale; Joanne L Dickinson; Patricia Groom; Laura J Johnson; Rex D Simmons; Brian Tait; Mike Varney; Bruce Taylor; Terence Dwyer; Robert Williamson; Nicholas M Gough; Trevor J Kilpatrick; Terence P Speed; Simon J Foote
Journal:  Am J Hum Genet       Date:  2002-03-29       Impact factor: 11.025

8.  Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.

Authors:  E Mignot; L Lin; W Rogers; Y Honda; X Qiu; X Lin; M Okun; H Hohjoh; T Miki; S Hsu; M Leffell; F Grumet; M Fernandez-Vina; M Honda; N Risch
Journal:  Am J Hum Genet       Date:  2001-02-13       Impact factor: 11.025

Review 9.  Genetics of multiple sclerosis.

Authors:  David A Dyment; George C Ebers; A Dessa Sadovnick
Journal:  Lancet Neurol       Date:  2004-02       Impact factor: 44.182

10.  Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease.

Authors:  B P C Koeleman; B A Lie; D E Undlien; F Dudbridge; E Thorsby; R R P de Vries; F Cucca; B O Roep; M J Giphart; J A Todd
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

View more
  51 in total

1.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.

Authors:  Alessandra Ferlini; Matteo Bovolenta; Marcella Neri; Francesca Gualandi; Alessandra Balboni; Anton Yuryev; Fabrizio Salvi; Donato Gemmati; Alberto Liboni; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

Review 3.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 4.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

5.  Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.

Authors:  Nathali Kaushansky; Miriam Eisenstein; Sigalit Boura-Halfon; Bjarke Endel Hansen; Claus Henrik Nielsen; Ron Milo; Gabriel Zeilig; Hans Lassmann; Daniel M Altmann; Avraham Ben-Nun
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

6.  The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression.

Authors:  Adam E Handel; Lahiru Handunnetthi; Antonio J Berlanga; Corey T Watson; Julia M Morahan; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

7.  Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat.

Authors:  Pernilla Stridh; Melanie Thessen Hedreul; Amennai Daniel Beyeen; Milena Z Adzemovic; Hannes Laaksonen; Alan Gillett; Johan Ockinger; Monica Marta; Hans Lassmann; Kristina Becanovic; Maja Jagodic; Tomas Olsson
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

8.  Multiple linked quantitative trait loci within the Tmevd2/Eae3 interval control the severity of experimental allergic encephalomyelitis in DBA/2J mice.

Authors:  K M Spach; L K Case; R Noubade; C B Petersen; B McElvany; N Zalik; W F Hickey; E P Blankenhorn; C Teuscher
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

9.  Multiple sclerosis: major histocompatibility complexity and antigen presentation.

Authors:  Sreeram V Ramagopalan; George C Ebers
Journal:  Genome Med       Date:  2009-11-06       Impact factor: 11.117

10.  The genetic basis of multiple sclerosis: a model for MS susceptibility.

Authors:  Douglas S Goodin
Journal:  BMC Neurol       Date:  2010-10-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.